The clinical significance of CT pulmonary perfusion imaging in clinical stage I non-small cell lung cancer
Ru Wang
Abstract
Ru Wang
Abstract
Objective:To discuss the role of multi-slice spiral CT(MSCT) pulmonary perfusion imaging in the evaluation of clinical stage Ⅰ non-small cell lung cancer(NSCLC).Methods:129 patients with NSCLC had MSCT perfusion imaging.Correlation analysis was made between CT perfusion parameters and pathology characteristics.Trend tests were used for the comparison of different groups.Results:There was correlation between CT perfusion parameters and pathology features of NSCLC.The blood flow(BF)of well-,middle-and poorly differentiated carcinoma was(58.3±20.5)、(38.5±15.7) and(30.3±6.7)ml/(100g·min) respectively,the peak enhanced index(PEI) was(26.1±11.7)、(23.6±6.9) and(16.2±4.9)HU respectively,with the p value as 0.01 and 0.023 respectively.The BF and PEI decreased with the decreasing of NSCLC differentiation grading.The BF value of NSCLC with lymph node metastasis was [(28.4±9.8)ml/(100g·min)] and the PEI was [(10.9±8.4)HU],which was obviously lower than that without lymph node metastases[(47.3±16.5)ml/(100g·min) and(24.0±8.7)HU] respectively,the p value was 0.000 and 0.002 respectively.The BF value of patients with post-surgery metastases was [(22.6±3.2)ml/(100g·min)],which was markedly lower than that with no metastasis [(45.0±16.4)ml/(100g·min)],with significant statistical difference(P0.001).No obvious differences were showed between the CT perfusion parameters of different pathology sub-types of NSCLC(P0.05).Conclusion:The mode and degree of angiogenesis of NSCLC could be evaluated by MSCT perfusion imaging,which is a non-invasive approach,could indirectly reflect the grade of tumor differentiation and predict the possibility of lymph node metastases as well as postoperative metastasis.MSCT pulmonary perfusion imaging can be used as a useful marker to judge the biological behavior and the prognosis of NSCLC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To discuss the role of multi-slice spiral CT(MSCT) pulmonary perfusion imaging in the evaluation of clinical stage Ⅰ non-small cell lung cancer(NSCLC).Methods:129 patients with NSCLC had MSCT perfusion imaging.Correlation analysis was made between CT perfusion parameters and pathology characteristics.Trend tests were used for the comparison of different groups.Results:There was correlation between CT perfusion parameters and pathology features of NSCLC.The blood flow(BF)of well-,middle-and poorly differentiated carcinoma was(58.3±20.5)、(38.5±15.7) and(30.3±6.7)ml/(100g·min) respectively,the peak enhanced index(PEI) was(26.1±11.7)、(23.6±6.9) and(16.2±4.9)HU respectively,with the p value as 0.01 and 0.023 respectively.The BF and PEI decreased with the decreasing of NSCLC differentiation grading.The BF value of NSCLC with lymph node metastasis was [(28.4±9.8)ml/(100g·min)] and the PEI was [(10.9±8.4)HU],which was obviously lower than that without lymph node metastases[(47.3±16.5)ml/(100g·min) and(24.0±8.7)HU] respectively,the p value was 0.000 and 0.002 respectively.The BF value of patients with post-surgery metastases was [(22.6±3.2)ml/(100g·min)],which was markedly lower than that with no metastasis [(45.0±16.4)ml/(100g·min)],with significant statistical difference(P0.001).No obvious differences were showed between the CT perfusion parameters of different pathology sub-types of NSCLC(P0.05).Conclusion:The mode and degree of angiogenesis of NSCLC could be evaluated by MSCT perfusion imaging,which is a non-invasive approach,could indirectly reflect the grade of tumor differentiation and predict the possibility of lymph node metastases as well as postoperative metastasis.MSCT pulmonary perfusion imaging can be used as a useful marker to judge the biological behavior and the prognosis of NSCLC.
Key concepts: Medicine, Perfusion, Lung cancer, Perfusion scanning, Nuclear medicine, Stage (stratigraphy), Grading (engineering), Metastasis